Back to Authors

Staley, Hannah A.

https://orcid.org/0009-0001-8284-6178

Mayo Clinic

University of Florida Health

Citations 2

Single-cell multiomics identifies both shared and unique features of immune dysfunction in Parkinson’s disease and inflammatory bowel disease colon, plasma and stool
Buendia, Marc, Shi, Ji , Kachergus, Jennifer M., Efron, Philip A. , Alvarez, Stephan D. , Xue, Qing‐Shan, Zimmermann, Ellen M. , Forsmark, Christopher E. , Thompson, E. Aubrey, Bolen, MacKenzie L. , Buendia, Marc, Staley, Hannah A. , Park, Gwoncheol , Nagpal, Ravinder , McFarland, Nikolaus R. , Menees, Kelly B , Salas, Azucena , Thompson, E. Aubrey, Tansey, Malú G.

No container title available | July 21, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-7115293/v1 Get It

Abstract Parkinson’s disease (PD) is the fastest growing neurodegenerative disease in the world1. Gastrointestinal (GI) dysfunction can occur decades before motor impairments and in up to 80% of individuals living with PD2,3,4. We investigated peripheral relationships that may underlie environmental contributions to mechanisms along the gut-blood axis that contribute to PD pathogenesis. Single-cell multiomic spatial molecular imaging (SMI) of colonic tissue localized inflammatory injury within epithelial cells that appear to be associated with iron mishandling in both inflammatory bowel disease (IBD) and PD biosamples. We found that both the single-cell SMI of RNA and protein revealed parallel cross-modal dysregulation in the gut epithelium, in both IBD and PD biosamples. These data are accompanied by plasma (PD) and stool (IBD) protein depletion of CCL22. Our findings suggest iron mishandling along the gut barrier likely contributes to systemic inflammation, which may be the catalyst that primes circulating immune cells to body-first PD pathogenesis.
Single-cell multiomics identifies both shared and unique features of immune dysfunction in Parkinson’s disease and inflammatory bowel disease colon, plasma and stool
Bolen, MacKenzie L. , Buendia, Marie‐Annick , Shi, Ji , Staley, Hannah A. , Kachergus, Jennifer M., Efron, Philip A. , Park, Gwoncheol , Nagpal, Ravinder , Alvarez, Stephan D. , Xue, Qing‐Shan, McFarland, Nikolaus R. , Zimmermann, Ellen M. , Forsmark, Christopher E. , Thompson, E. Aubrey, Buendia, Marc , Staley, Hannah , Menees, Kelly B , Tansey, Malú G , McFarland, Nikolaus R , Buendia, Marc, Salas, Azucena , Thompson, E. Aubrey, Tansey, Malú G.

No container title available | May 2, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1101/2025.04.29.651228 Get It

Abstract Parkinson’s disease (PD) is the fastest growing neurodegenerative disease in the world 1 . Gastrointestinal (GI) dysfunction can occur decades before motor impairments and in up to 80% of individuals living with PD 2,3,4 . We investigated peripheral relationships that may underlie mechanisms along the gut-blood axis that contribute to PD pathogenesis. Single-cell multiomic spatial molecular imaging (SMI) of colonic tissue localized inflammatory injury within epithelial cells that appear to be associated with iron mishandling in both inflammatory bowel disease (IBD) and PD biosamples. We found that both the single-cell SMI of RNA and protein revealed parallel cross-modal dysregulation in the gut epithelium, in both IBD and PD biosamples. These data are accompanied by plasma (PD) and stool (IBD) protein depletion of CCL22. Our findings suggest iron mishandling along the gut barrier likely contributes to systemic inflammation, which may be the catalyst that primes circulating immune cells to body-first PD pathogenesis.